REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

Thymosin Alpha-1 Mechanism of Action

How Thymosin Alpha-1 works: receptor targets, signalling pathways, and molecular profile.

RE
Compiled from published research · Continuously updated

A Thymic Immune-Signaling Peptide

Thymosin Alpha-1 is a fragment of prothymosin alpha, naturally produced by the thymus gland, where it plays a role in T-cell maturation and differentiation. It also acts as a TLR9 (Toll-like receptor 9) agonist, engaging innate immune pathways — a dual innate/adaptive immune-signaling profile that underlies its use as a general immune-modulating agent.

Broad Immunomodulatory Applications

Because it touches both innate and adaptive immunity, Thymosin Alpha-1 has been studied across a wide range of applications — chronic viral hepatitis, as an adjunct to vaccines and cancer immunotherapy, and general immune support — rather than one narrow mechanism-to-outcome pathway.

References

  1. Thymosin-α1 for people with chronic hepatitis B (Cochrane Review CD014610) · Htet NH, et al. · 2022
All Thymosin Alpha-1 sections

Oxytocin

longevity & healthspanBgrade

A naturally occurring nonapeptide — FDA-approved as Pitocin for labor, and separately studied off-label (intranasal) for social bonding and stress research.

SS-31 (Elamipretide)

longevity & healthspanBgrade

A mitochondria-targeting tetrapeptide, FDA-approved in September 2025 for Barth syndrome — a real approval in one narrow rare disease, not a general muscle or longevity drug.

Humanin

longevity & healthspanCgrade

A mitochondrial-derived peptide discovered protecting neurons from Alzheimer's-linked toxicity — cell and rodent data only, no human trial exists.

Put the whole protocol
in one place.

Download nowGet Now